Menopause Costs U.S. Women $1.8B in Lost Wages. And Care Gaps Are Growing

July 30 21:30 2026

Kamloops, British Columbia – A 2023 Mayo Clinic study published in Mayo Clinic Proceedings estimated that menopause symptoms cost U.S. employers $1.8 billion annually in lost working time. And that figure doesn’t count the women who quietly reduce hours, turn down promotions, or exit the workforce entirely because no one has addressed the hormonal root cause. Karen Martel Midlife Solutions, a functional medicine clinic founded by Certified Hormone Specialist Karen Martel, is expanding its direct-access hormone care programs this month to reach the estimated 6,000 women who enter perimenopause every day in the United States without a clear clinical path forward.

Key Facts: The Mayo Clinic study (Mayo Clinic Proceedings, 2023) found menopause symptoms cost U.S. employers an estimated $1.8 billion per year in lost working time. Based on survey data from 4,440 women aged 45-60. A 2024 report from the Menopause Society (formerly NAMS) found that fewer than 1 in 5 OB/GYN residency programs include dedicated menopause training. Leaving most women without access to a practitioner who can competently prescribe hormone therapy. According to the U.S. Census Bureau, approximately 55 million American women are currently between the ages of 40 and 65. The window when perimenopause and menopause symptoms are most clinically active. Karen Martel’s clinical programs combine validated hormone panel testing with individualized bioidentical HRT protocols, peptide therapy, and nutritional coaching. Structured around root cause analysis, not symptom suppression. The clinic’s group coaching tier brings evidence-based hormone education to women who aren’t yet ready for or eligible for full clinical programs. Closing the information gap before it becomes a health crisis. Karen Martel’s podcast, The Hormone Solution, has surpassed 5 million downloads, reflecting the demand for medically grounded midlife health information that’s largely absent from mainstream clinical settings.

The workforce cost data is striking. But the more important number is the one that doesn’t show up in employer spreadsheets: the years women spend being told their symptoms are normal, their labs are “fine,” and that fatigue, weight gain, brain fog, and sleep disruption are just part of getting older. Most conventional clinical settings still aren’t equipped to challenge that narrative.

That gap is structural, not incidental. The Menopause Society’s 2024 training data makes it plain. When most OB/GYNs graduate without formal menopause training, the standard of care defaults to waiting, reassuring, and prescribing antidepressants. Women who don’t match a narrow diagnostic window get dismissed. The ones who push back often end up spending years cycling through practitioners before finding one who will actually test their hormones and act on what they find.

Karen Martel’s approach starts where conventional care stops. Each clinical program begins with comprehensive hormone panel testing, not a single estradiol reading, and uses that data to build a protocol specific to where a woman is in her hormonal transition. Bioidentical hormone replacement, where indicated, is dosed and monitored over time. Peptide protocols, targeted supplementation, and nutrition coaching address what hormones alone don’t fix. Consider a woman in her late 40s whose TSH is technically “normal” but whose free T3, progesterone, and cortisol tell a different story. That woman gets missed entirely by a standard 15-minute visit. She’s not an edge case. She’s the majority of the clinic’s intake.

The expansion announced today adds capacity across the clinical hormone replacement tier and group coaching cohorts, with intake open now at karenmartel.com.

Executive Quotes

Karen Martel, Founder and Certified Hormone Specialist, Karen Martel Midlife Solutions:

“The $1.8 billion figure gets cited as a workplace productivity problem. It’s actually a healthcare failure. Women aren’t losing work capacity because menopause is inherently debilitating. They’re losing it because the symptoms go untreated for years. Bioidentical hormone therapy, when properly tested and dosed, doesn’t just reduce symptoms. It restores function. The data on that is solid. What’s missing isn’t evidence. It’s access.”

Karen Martel, on the training gap in conventional medicine:

“When the Menopause Society tells you fewer than 20% of OB/GYN programs include real menopause training, you have to stop calling the dismissal women experience a bedside manner problem. It’s a knowledge gap baked into medical education. Women aren’t imagining their symptoms. Their doctors are genuinely underprepared to address them. That’s why functional medicine exists. And why direct-access programs matter more right now than they ever have.”

About Karen Martel

Karen Martel Midlife Solutions is an all-female, expert-led functional medicine clinic founded by Karen Martel, a Certified Hormone Specialist and Transformational Nutrition Coach. The clinic offers personalized perimenopause and menopause care through hormone testing, bioidentical HRT programs, peptide therapy, and clinical coaching. Structured around root cause analysis for women who haven’t found real answers in conventional medical settings. Karen’s podcast, The Hormone Solution, has surpassed 5 million downloads and is one of the most widely followed independent resources on women’s midlife hormone health.

Media Contact
Company Name: Midlife Solutions
Contact Person: Karen Martel
Email: Send Email
City: Kamloops
State: British Columbia
Country: Canada
Website: http://karenmartel.com/

view more articles

About Article Author